
Covetrus CVET
Quartalsbericht 2022-Q2
hinzugefügt 16.12.2023
Covetrus DSO 2011-2026 | CVET
DSO Jährlich Covetrus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 39.4 | 39.2 | 19.6 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 39.4 | 19.6 | 32.7 |
DSO Vierteljährlich Covetrus
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 40.5 | - | 39.6 | 39.7 | 42.4 | 41.3 | 41.1 | 45.1 | 40 | 38.6 | 38.2 | 38.5 | 41.5 | 43.5 | 42.6 | 39.1 | 20.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.1 | 20.8 | 39.5 |
DSO anderer Aktien in der Gesundheitsdienste
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
9.76 | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
73.8 | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
89 | $ 5.55 | -1.42 % | $ 89.1 M | ||
|
Computer Programs and Systems
CPSI
|
59.7 | - | 4.4 % | $ 133 M | ||
|
Schrödinger
SDGR
|
227 | $ 11.52 | 1.05 % | $ 846 M | ||
|
Phreesia
PHR
|
59.5 | $ 11.52 | 2.49 % | $ 629 M | ||
|
Castlight Health, Inc.
CSLT
|
79 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
144 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
94.4 | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
127 | - | - | $ 102 M | ||
|
Teladoc Health
TDOC
|
29.4 | $ 5.52 | -0.9 % | $ 973 M | ||
|
Evolent Health
EVH
|
210 | $ 2.3 | 1.55 % | $ 216 M | ||
|
NextGen Healthcare
NXGN
|
51.6 | - | - | $ 1.6 B | ||
|
10x Genomics
TXG
|
64.6 | $ 20.97 | 0.29 % | $ 2.46 B | ||
|
1Life Healthcare
ONEM
|
50.2 | - | - | $ 3.37 B | ||
|
MTBC
MTBC
|
42.2 | - | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
139 | - | - | $ 2.33 B | ||
|
GoodRx Holdings
GDRX
|
66.7 | $ 2.06 | -0.24 % | $ 795 M | ||
|
SCWorx Corp.
WORX
|
41.4 | $ 0.14 | 7.38 % | $ 204 K | ||
|
Signify Health
SGFY
|
272 | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
27.5 | - | - | $ 3.81 B | ||
|
HealthStream
HSTM
|
40.4 | $ 21.24 | 0.05 % | $ 645 M | ||
|
Akerna Corp.
KERN
|
7.62 | - | - | $ 161 M | ||
|
Zhongchao
ZCMD
|
116 | $ 1.78 | -1.11 % | $ 9.27 M | ||
|
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
81.9 | - | -10.39 % | $ 886 M | ||
|
Health Catalyst
HCAT
|
68.2 | $ 1.09 | -0.91 % | $ 76.2 M | ||
|
NantHealth
NH
|
32 | - | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
33.6 | $ 83.31 | 1.01 % | $ 7.18 B | ||
|
Omnicell
OMCL
|
83.4 | $ 35.35 | 1.17 % | $ 1.63 B | ||
|
OptimizeRx Corporation
OPRX
|
149 | $ 7.0 | -2.51 % | $ 120 M | ||
|
Tabula Rasa HealthCare
TRHC
|
24.8 | - | - | $ 255 M | ||
|
Progyny
PGNY
|
292 | $ 17.91 | 0.9 % | $ 1.54 B | ||
|
So-Young International
SY
|
-6.34 K | $ 2.88 | -9.87 % | $ 229 M | ||
|
Veeva Systems
VEEV
|
130 | $ 180.16 | 1.17 % | $ 29.5 B |